APA (7th ed.) Citation

Porth, I., Hirsch, D., Ceribas, Y., Weidner, P., Weichert, W., Götze, T., . . . Gaiser, T. (2023). Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. European journal of cancer, 183, . https://doi.org/10.1016/j.ejca.2023.01.022

Chicago Style (17th ed.) Citation

Porth, Isabel, et al. "Comprehensive Biomarker Analysis of Long-term Response to Trastuzumab in Patients with HER2-positive Advanced Gastric or Gastroesophageal Adenocarcinoma." European Journal of Cancer 183 (2023). https://doi.org/10.1016/j.ejca.2023.01.022.

MLA (9th ed.) Citation

Porth, Isabel, et al. "Comprehensive Biomarker Analysis of Long-term Response to Trastuzumab in Patients with HER2-positive Advanced Gastric or Gastroesophageal Adenocarcinoma." European Journal of Cancer, vol. 183, 2023, https://doi.org/10.1016/j.ejca.2023.01.022.